Kiernan T. DeAngelis
Directeur Technique/Scientifique/R&D chez Humacyte Global, Inc.
Profil
Kiernan T.
DeAngelis is currently the Chief Medical Officer at Humacyte Global, Inc. Prior to this, he served as the Global Medical Director at AstraZeneca PLC from 2017 to 2019 and as the Senior Medical Director at United Therapeutics Corp.
from 2013 to 2017.
He also previously held the position of Chief Medical Officer at Humacyte, Inc. from 2020 to 2021.
Dr. DeAngelis completed his undergraduate degree at North Carolina State University and obtained his doctorate from Brody School of Medicine.
Postes actifs de Kiernan T. DeAngelis
| Sociétés | Poste | Début |
|---|---|---|
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Directeur Technique/Scientifique/R&D | 01/04/2020 |
Anciens postes connus de Kiernan T. DeAngelis
| Sociétés | Poste | Fin |
|---|---|---|
| HUMACYTE, INC. | Directeur Technique/Scientifique/R&D | 01/10/2021 |
| ASTRAZENECA PLC | Directeur Technique/Scientifique/R&D | 01/09/2019 |
| UNITED THERAPEUTICS CORPORATION | Directeur Technique/Scientifique/R&D | 01/05/2017 |
Formation de Kiernan T. DeAngelis
| North Carolina State University | Undergraduate Degree |
| Brody School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| HUMACYTE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |